CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 304 enrolled
Drug / intervention
Topical IBU twice daily +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01945034
NCT01945034Phase 3Completed

Placebo-controlled, Double-blind Evaluation Of The Efficacy And Safety Of Ibuprofen 5% Topical Gel For The Treatment Of Ankle Sprain

Pfizer·interventional·Posted Sep 18, 2013·Updated May 26, 2016

In Brief

A Phase 3 clinical trial evaluating Topical IBU twice daily, Placebo twice daily, and 2 other interventions for Ankle Injuries. Completed, enrolled 304 participants across 19 sites.

Detailed Summary

This study is being conducted to evaluate the effects of IBU 5% Topical Gel versus topical placebo for the relief of pain associated with a first or second degree ankle sprain. Both twice daily and three times daily regimens will be evaluated.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAnkle Injuries
CountriesUnited States
Collaborators--

Timeline

Phase 3CompletedFinished
2014201520162017201820192020202120222023202420252026
First PostedSep 18, 2013
Enrollment StartNov 1, 2013
Primary CompletionFeb 1, 2015
TodayJul 2, 2026
Enrollment to primary: 1.3 yearsPosted 12.8 years ago

Interventions

Topical IBU twice dailydrug

Topical gel administered as 4 inch strip twice daily for 7 days, and as needed for an additional 3 days

Placebo twice dailydrug

Topical gel administered as a 4 inch strip twice daily for 7 days, and as needed for an additional 3 days

Topical IBU three times dailydrug

Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days

Placebo three times dailydrug

Topical gel administered as a 4 inch strip three times daily for 7 days, and as needed for additional 3 days